CG Oncology, Inc.
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.81M | -41.43M | -34.45M | -31.80M | -20.41M |
| Total Depreciation and Amortization | 416.00K | 156.00K | 24.00K | 0.00 | 21.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.37M | 4.65M | 4.68M | 6.24M | 1.06M |
| Change in Net Operating Assets | -2.87M | 8.66M | 469.00K | 4.90M | 3.40M |
| Cash from Operations | -38.89M | -27.96M | -29.28M | -20.66M | -15.92M |
| Capital Expenditure | -97.00K | -14.00K | -16.00K | -209.00K | 1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -21.97M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.11M | 1.42M | -186.75M | 11.11M | 32.00M |
| Cash from Investing | 15.05M | 1.41M | -186.77M | 10.91M | 32.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 54.10M | 19.00K | 682.00K | 223.41M | 2.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 270.00K | -315.00K | -232.00K | 0.00 | 0.00 |
| Cash from Financing | 54.37M | -296.00K | 450.00K | 223.41M | 2.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.52M | -26.85M | -215.60M | 213.66M | 18.25M |